SPOKANE, Wash.--(BUSINESS WIRE)--Signature Genomic Laboratories, LLC announced today that jVen Capital, a life sciences investment company with a focus in the areas of biotechnology, diagnostics, and medical devices, has acquired an equity interest in the company. In conjunction with the investment Evan Jones, the principle of jVen Capital, has been appointed Chairman of Signature’s Board of Directors.
